Earnings Call · Q4 FY2024·2025-02-27

Q4 24EPS +1.52%·Rev n/aQ3 24EPS +11.11%·Rev n/aQ2 24EPS -2.94%·Rev n/aQ1 24EPS +2.86%·Rev n/a⚠ consensus missing

Altimmune, Inc. ALT

Lee Roth — Unknown - likely investor relations or communications

Vipin Garg — Chief Executive Officer

Scott Harris — Chief Medical Officer

Greg Weaver — Chief Financial Officer

+8.1%1d on move date+9.7% vs SPY3d+0.8%5d−3.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALT calls or request research access.

More ALT calls Browse calls Request research access